"World's Most Complete Market Research Reports Repository"

Global Tardive Dyskinesia Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • Category : Healthcare & Pharma
  • |
  • ID : 675272
  • |
  • Publishe Date : 6-Nov-18
  • |
  • No of Pages: 101
  • |
  • Publisher : Global Info Research

Tardive Dyskinesia (TD) market is estimated to post significant growth in coming years, owing to rising schizophrenia patients, increasing bipolar patients, growing antipsychotic prescription and increasing incidence of neurological disorders.



Scope of the Report:

This report studies the Tardive Dyskinesia market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Tardive Dyskinesia market by product type and applications/end industries.

The key factors driving the growth of the Tardive dyskinesia market are rising schizophrenia patients, increasing bipolar patients, growing antipsychotic prescription, increased use of long-term neuroleptic drugs and increasing incidence of neurological disorders. However, the expansion of the market is hindered by side effects of drugs and under-diagnosed.

The global Tardive Dyskinesia market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Tardive Dyskinesia.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.



Market Segment by Companies, this report covers

Valeant Pharmaceuticals

Neurocrine Biosciences

Teva Pharmaceuticals Industries



Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)



Market Segment by Type, covers

Dopamine-Depleting Medications

GABA Receptor Agonist Medications

Anticholinergic Medications



Market Segment by Applications, can be divided into

Hospitals

Ambulatory Surgical Centers

Diagnostic Centers

Table of Contents



1 Tardive Dyskinesia Market Overview

1.1 Product Overview and Scope of Tardive Dyskinesia

1.2 Classification of Tardive Dyskinesia by Types

1.2.1 Global Tardive Dyskinesia Revenue Comparison by Types (2017-2023)

1.2.2 Global Tardive Dyskinesia Revenue Market Share by Types in 2017

1.2.3 Dopamine-Depleting Medications

1.2.4 GABA Receptor Agonist Medications

1.2.5 Anticholinergic Medications

1.3 Global Tardive Dyskinesia Market by Application

1.3.1 Global Tardive Dyskinesia Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Diagnostic Centers

1.4 Global Tardive Dyskinesia Market by Regions

1.4.1 Global Tardive Dyskinesia Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Tardive Dyskinesia Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Tardive Dyskinesia Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Tardive Dyskinesia Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Tardive Dyskinesia Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Tardive Dyskinesia Status and Prospect (2013-2023)

1.5 Global Market Size of Tardive Dyskinesia (2013-2023)

2 Manufacturers Profiles

2.1 Valeant Pharmaceuticals

2.1.1 Business Overview

2.1.2 Tardive Dyskinesia Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Valeant Pharmaceuticals Tardive Dyskinesia Revenue, Gross Margin and Market Share (2016-2017)

2.2 Neurocrine Biosciences

2.2.1 Business Overview

2.2.2 Tardive Dyskinesia Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Neurocrine Biosciences Tardive Dyskinesia Revenue, Gross Margin and Market Share (2016-2017)

2.3 Teva Pharmaceuticals Industries

2.3.1 Business Overview

2.3.2 Tardive Dyskinesia Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Teva Pharmaceuticals Industries Tardive Dyskinesia Revenue, Gross Margin and Market Share (2016-2017)

3 Global Tardive Dyskinesia Market Competition, by Players

3.1 Global Tardive Dyskinesia Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Tardive Dyskinesia Players Market Share

3.2.2 Top 10 Tardive Dyskinesia Players Market Share

3.3 Market Competition Trend

4 Global Tardive Dyskinesia Market Size by Regions

4.1 Global Tardive Dyskinesia Revenue and Market Share by Regions

4.2 North America Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

4.3 Europe Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

4.5 South America Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

5 North America Tardive Dyskinesia Revenue by Countries

5.1 North America Tardive Dyskinesia Revenue by Countries (2013-2018)

5.2 USA Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

5.3 Canada Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

5.4 Mexico Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

6 Europe Tardive Dyskinesia Revenue by Countries

6.1 Europe Tardive Dyskinesia Revenue by Countries (2013-2018)

6.2 Germany Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

6.3 UK Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

6.4 France Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

6.5 Russia Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

6.6 Italy Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Tardive Dyskinesia Revenue by Countries

7.1 Asia-Pacific Tardive Dyskinesia Revenue by Countries (2013-2018)

7.2 China Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

7.3 Japan Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

7.4 Korea Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

7.5 India Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

8 South America Tardive Dyskinesia Revenue by Countries

8.1 South America Tardive Dyskinesia Revenue by Countries (2013-2018)

8.2 Brazil Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

8.3 Argentina Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

8.4 Colombia Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Tardive Dyskinesia by Countries

9.1 Middle East and Africa Tardive Dyskinesia Revenue by Countries (2013-2018)

9.2 Saudi Arabia Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

9.3 UAE Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

9.4 Egypt Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

9.5 Nigeria Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

9.6 South Africa Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

10 Global Tardive Dyskinesia Market Segment by Type

10.1 Global Tardive Dyskinesia Revenue and Market Share by Type (2013-2018)

10.2 Global Tardive Dyskinesia Market Forecast by Type (2018-2023)

10.3 Dopamine-Depleting Medications Revenue Growth Rate (2013-2023)

10.4 GABA Receptor Agonist Medications Revenue Growth Rate (2013-2023)

10.5 Anticholinergic Medications Revenue Growth Rate (2013-2023)

11 Global Tardive Dyskinesia Market Segment by Application

11.1 Global Tardive Dyskinesia Revenue Market Share by Application (2013-2018)

11.2 Tardive Dyskinesia Market Forecast by Application (2018-2023)

11.3 Hospitals Revenue Growth (2013-2018)

11.4 Ambulatory Surgical Centers Revenue Growth (2013-2018)

11.5 Diagnostic Centers Revenue Growth (2013-2018)

12 Global Tardive Dyskinesia Market Size Forecast (2018-2023)

12.1 Global Tardive Dyskinesia Market Size Forecast (2018-2023)

12.2 Global Tardive Dyskinesia Market Forecast by Regions (2018-2023)

12.3 North America Tardive Dyskinesia Revenue Market Forecast (2018-2023)

12.4 Europe Tardive Dyskinesia Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Tardive Dyskinesia Revenue Market Forecast (2018-2023)

12.6 South America Tardive Dyskinesia Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Tardive Dyskinesia Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure Tardive Dyskinesia Picture

Table Product Specifications of Tardive Dyskinesia

Table Global Tardive Dyskinesia and Revenue (Million USD) Market Split by Product Type

Figure Global Tardive Dyskinesia Revenue Market Share by Types in 2017

Figure Dopamine-Depleting Medications Picture

Figure GABA Receptor Agonist Medications Picture

Figure Anticholinergic Medications Picture

Table Global Tardive Dyskinesia Revenue (Million USD) by Application (2013-2023)

Figure Tardive Dyskinesia Revenue Market Share by Applications in 2017

Figure Hospitals Picture

Figure Ambulatory Surgical Centers Picture

Figure Diagnostic Centers Picture

Table Global Market Tardive Dyskinesia Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Tardive Dyskinesia Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Tardive Dyskinesia Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Tardive Dyskinesia Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Tardive Dyskinesia Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Tardive Dyskinesia Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Tardive Dyskinesia Revenue (Million USD) and Growth Rate (2013-2023)

Table Valeant Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Valeant Pharmaceuticals Tardive Dyskinesia Type and Applications

Table Valeant Pharmaceuticals Tardive Dyskinesia Revenue, Gross Margin and Market Share (2016-2017)

Table Neurocrine Biosciences Basic Information, Manufacturing Base and Competitors

Table Neurocrine Biosciences Tardive Dyskinesia Type and Applications

Table Neurocrine Biosciences Tardive Dyskinesia Revenue, Gross Margin and Market Share (2016-2017)

Table Teva Pharmaceuticals Industries Basic Information, Manufacturing Base and Competitors

Table Teva Pharmaceuticals Industries Tardive Dyskinesia Type and Applications

Table Teva Pharmaceuticals Industries Tardive Dyskinesia Revenue, Gross Margin and Market Share (2016-2017)

Table Global Tardive Dyskinesia Revenue (Million USD) by Players (2013-2018)

Table Global Tardive Dyskinesia Revenue Share by Players (2013-2018)

Figure Global Tardive Dyskinesia Revenue Share by Players in 2016

Figure Global Tardive Dyskinesia Revenue Share by Players in 2017

Figure Global Top 5 Players Tardive Dyskinesia Revenue Market Share in 2017

Figure Global Top 10 Players Tardive Dyskinesia Revenue Market Share in 2017

Figure Global Tardive Dyskinesia Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Tardive Dyskinesia Revenue (Million USD) by Regions (2013-2018)

Table Global Tardive Dyskinesia Revenue Market Share by Regions (2013-2018)

Figure Global Tardive Dyskinesia Revenue Market Share by Regions (2013-2018)

Figure Global Tardive Dyskinesia Revenue Market Share by Regions in 2017

Figure North America Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

Figure Europe Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

Figure South America Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

Table North America Tardive Dyskinesia Revenue by Countries (2013-2018)

Table North America Tardive Dyskinesia Revenue Market Share by Countries (2013-2018)

Figure North America Tardive Dyskinesia Revenue Market Share by Countries (2013-2018)

Figure North America Tardive Dyskinesia Revenue Market Share by Countries in 2017

Figure USA Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

Figure Canada Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

Figure Mexico Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

Table Europe Tardive Dyskinesia Revenue (Million USD) by Countries (2013-2018)

Figure Europe Tardive Dyskinesia Revenue Market Share by Countries (2013-2018)

Figure Europe Tardive Dyskinesia Revenue Market Share by Countries in 2017

Figure Germany Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

Figure UK Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

Figure France Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

Figure Russia Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

Figure Italy Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Tardive Dyskinesia Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Tardive Dyskinesia Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Tardive Dyskinesia Revenue Market Share by Countries in 2017

Figure China Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

Figure Japan Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

Figure Korea Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

Figure India Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

Table South America Tardive Dyskinesia Revenue by Countries (2013-2018)

Table South America Tardive Dyskinesia Revenue Market Share by Countries (2013-2018)

Figure South America Tardive Dyskinesia Revenue Market Share by Countries (2013-2018)

Figure South America Tardive Dyskinesia Revenue Market Share by Countries in 2017

Figure Brazil Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

Figure Argentina Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

Figure Colombia Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Tardive Dyskinesia Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Tardive Dyskinesia Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Tardive Dyskinesia Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Tardive Dyskinesia Revenue Market Share by Countries in 2017

Figure Saudi Arabia Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

Figure UAE Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

Figure Egypt Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

Figure Nigeria Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

Figure South Africa Tardive Dyskinesia Revenue and Growth Rate (2013-2018)

Table Global Tardive Dyskinesia Revenue (Million USD) by Type (2013-2018)

Table Global Tardive Dyskinesia Revenue Share by Type (2013-2018)

Figure Global Tardive Dyskinesia Revenue Share by Type (2013-2018)

Figure Global Tardive Dyskinesia Revenue Share by Type in 2017

Table Global Tardive Dyskinesia Revenue Forecast by Type (2018-2023)

Figure Global Tardive Dyskinesia Market Share Forecast by Type (2018-2023)

Figure Global Dopamine-Depleting Medications Revenue Growth Rate (2013-2018)

Figure Global GABA Receptor Agonist Medications Revenue Growth Rate (2013-2018)

Figure Global Anticholinergic Medications Revenue Growth Rate (2013-2018)

Table Global Tardive Dyskinesia Revenue by Application (2013-2018)

Table Global Tardive Dyskinesia Revenue Share by Application (2013-2018)

Figure Global Tardive Dyskinesia Revenue Share by Application (2013-2018)

Figure Global Tardive Dyskinesia Revenue Share by Application in 2017

Table Global Tardive Dyskinesia Revenue Forecast by Application (2018-2023)

Figure Global Tardive Dyskinesia Market Share Forecast by Application (2018-2023)

Figure Global Hospitals Revenue Growth Rate (2013-2018)

Figure Global Ambulatory Surgical Centers Revenue Growth Rate (2013-2018)

Figure Global Diagnostic Centers Revenue Growth Rate (2013-2018)

Figure Global Tardive Dyskinesia Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Tardive Dyskinesia Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Tardive Dyskinesia Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Tardive Dyskinesia Revenue Market Forecast (2018-2023)

Figure Europe Tardive Dyskinesia Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Tardive Dyskinesia Revenue Market Forecast (2018-2023)

Figure South America Tardive Dyskinesia Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Tardive Dyskinesia Revenue Market Forecast (2018-2023)

Choose License Type